Back to Search Start Over

Retroperitoneal Fibrosis: Beware of Lymphoma.

Authors :
Ouchani M
Bachir H
Hamaz S
Alaoui H
Serraj K
Source :
Cureus [Cureus] 2021 Aug 31; Vol. 13 (8), pp. e17587. Date of Electronic Publication: 2021 Aug 31 (Print Publication: 2021).
Publication Year :
2021

Abstract

Retroperitoneal fibrosis is a rare disease manifesting as chronic soft tissue fibrosis in the retroperitoneum, with potential anatomic and/or functional compromise of adjacent organs. It can be primary (idiopathic) or secondary to other conditions such as cancers, radiotherapy, surgery, traumatisms, infections, autoimmune disorders, or drugs. We report herein a 54-year-old patient with symptomatic retroperitoneal fibrosis leading to bilateral hydronephrosis and renal failure, in whom, after a complex diagnostic workup and protracted clinical course, a follicular lymphoma in the retroperitoneal was identified. The patient was treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy protocol, with a resolution of hydronephrosis and lower back pain. We include a thorough literature review on etiopathogenesis, diagnosis, therapy, and prognosis of retroperitoneal fibrosis. A meticulous search for malignancy is necessary for this rare condition that, if positive, may have significant therapeutic and prognostic implications.<br />Competing Interests: The authors have declared that no competing interests exist.<br /> (Copyright © 2021, Ouchani et al.)

Details

Language :
English
ISSN :
2168-8184
Volume :
13
Issue :
8
Database :
MEDLINE
Journal :
Cureus
Publication Type :
Report
Accession number :
34646640
Full Text :
https://doi.org/10.7759/cureus.17587